A detailed history of Crewe Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Crewe Advisors LLC holds 10,819 shares of MRK stock, worth $1.36 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
10,819
Holding current value
$1.36 Million
% of portfolio
0.17%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $1.23 Million - $1.43 Million
10,819 New
10,819 $1.43 Million
Q2 2023

Jul 28, 2023

BUY
$108.61 - $118.38 $10,861 - $11,838
100 Added 0.9%
11,170 $1.29 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $32,323 - $36,066
-314 Reduced 2.76%
11,070 $1.18 Million
Q4 2022

Feb 07, 2023

BUY
$87.44 - $112.11 $35,937 - $46,077
411 Added 3.75%
11,384 $1.26 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $39,898 - $44,821
472 Added 4.49%
10,973 $945,000
Q2 2022

Aug 02, 2022

BUY
$83.49 - $94.64 $126,320 - $143,190
1,513 Added 16.83%
10,501 $957,000
Q1 2022

Apr 27, 2022

BUY
$73.51 - $82.4 $489,503 - $548,701
6,659 Added 285.92%
8,988 $737,000
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $159,305 - $199,550
2,204 Added 1763.2%
2,329 $178,000
Q2 2021

Aug 11, 2021

SELL
$70.31 - $77.77 $38,740 - $42,851
-551 Reduced 81.51%
125 $10,000
Q1 2021

Apr 21, 2021

SELL
$68.86 - $81.11 $4,269 - $5,028
-62 Reduced 8.4%
676 $52,000
Q4 2020

Jan 27, 2021

SELL
$71.77 - $79.65 $9,545 - $10,593
-133 Reduced 15.27%
738 $60,000
Q3 2020

Oct 13, 2020

BUY
$73.18 - $82.95 $54,592 - $61,880
746 Added 596.8%
871 $72,000
Q3 2019

Nov 06, 2019

BUY
$76.08 - $82.93 $8,977 - $9,785
118 Added 1685.71%
125 $11,000
Q1 2019

May 10, 2019

BUY
$69.58 - $79.36 $487 - $555
7 New
7 $1,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.